Helicobacter pylori infection and cancer

British Medical Bulletin

Volumn 54, Issue 1, 1998, Pages 71-78

  Forman, David ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; REVIEW; STOMACH CANCER; STOMACH PH;

EID: 0031950636     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011682     Document Type: Review

References (57)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606
2. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997; 349: 1269-76
3. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in Cancer Incidence and Mortality. IARC Scientific Publications No 121. Lyon: IARC, 1993
4. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-504
5. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J. Survival of Cancer Patients in Europe: The Eurocare Study. IARC Scientific Publications No 132. Lyon: IARC, 1995
6. International Agency for Research on Cancer. Schistosomes, Liver Flukes and Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans No 61. Lyon: IARC, 1994
7. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process - first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 1992; 52: 6735-40
8. Kuipers EJ, Uyterlinde AM, Peña AS et al. Long-term sequelae of Helicobacter pylori gastritis. Lancet 1995; 345: 1525-8
9. Goodman KJ, Correa P. The transmission of Helicobacter pylori. A critical review of the evidence. Int J Epidemiol 1995; 24: 875-87
10. Forman D, Sitas F, Newell DG et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608-11
11. Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62
12. Forman D. The prevalence of Helicobacter pylori infection in gastric cancer. Ailment Pharmacol Ther 1995; 9: 71-6
13. Karnes WE, Samloff IM, Siurala M et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991; 101: 167-74
14. Webb PM, Forman D. Helicobacter pylori as a risk factor for cancer. Bailliere's Clin Gastroenterol 1995; 9: 563-82
15. Kikuchi S, Wada O, Nakajima T et al and Research Group on Prevention of Gastric Carcinoma among Young Adults. Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 1995; 75: 2789-93
16. Hansson LE, Engstrand L, Nyren O et al. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 1993; 105: 1098-103
17. Forman D, Newell DG, Fullerton F et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302: 1302-5
18. Parsonnet J, Friedman GD, Vandersteen DP et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325: 1127-31
19. Nomura A, Stemmermann GN, Chyou PH, Kato I, Pérez-Pérez GI, Blaser MJ. Helicobacter pylori and gastric carcinoma among Japanese Americans in Hawaii. N Eng J Med 1991; 325: 1132-6
20. Webb PM, Yu MC, Forman D et al. An apparent lack of association between Helicobacter pylori infection and risk of gastric cancer in China. Int J Cancer 1996; 67: 603-7
21. Lin JT, Wang LY, Wang JT, Wang TH, Yang CS, Chen CJ. A nested case-control study on the association between Helicobacter pylori infection and gastric cancer risk in a cohort of 9775 men in Taiwan. Anticancer Res 1995; 15: 603-6
22. Hansen S, Vollset SE, Melby K, Jellum E. Strong association of previous Helicobacter pylori infection to distal gastric adenocarcinoma [Abstract]. Am J Gastroenterol 1994; 89: 1358
23. Aromaa A, Kosunen TU, Knekt P et al. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen 1 levels are associated with increased risk of gastric cancer. Am J Epidemiol 1996; 144: 142-8
24. Simán JH, Forsgren A, Florén C-H. Association between Helicobacter pylori and gastric carcinoma in the city of Malmö, Sweden. A prospective study [Abstract]. Gut 1997; 41: A45
25. Forman D, Webb P, Parsonnet J. Helicobacter pylori and gastric cancer. Lancet 1994; 343: 243-4
26. Pisani P, Maxwell Parkin D, Muñoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997; 6: 387-400
27. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents Volume VI. International Agency for Research on Cancer Scientific Publication No. 120. Lyon: IARC, 1992
28. The EUROGAST Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut 1993; 34: 1672-6
29. Replogle ML, Glaser SL, Hiatt RA, Parsonnet J. Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. Am J Epidemiol 1995; 142: 856-63
30. Tsugane S, Kabuto M, Imai H et al. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993; 4: 297-305
31. Palli D, Decarli A, Cipriani F et al. Helicobacter pylori antibodies in areas of Italy at varying gastric cancer risk. Cancer Epidemiol Biomarkers Prev 1993; 2: 37-40
32. Holcombe C. Helicobacter pylori: the African enigma. Gut 1992; 33: 429-31
33. Kono S, Hirohata T. Nutrition and stomach cancer. Cancer Causes Control 1996; 7: 41-55
34. El-Omar E, Penman I, Ardill JES, McColl KEL. A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients. Gut 1995; 36: 534-8
35. McColl KE, El-Omar E. Helicobacter pylori and disturbance of gastric function associated with duodenal ulcer disease and gastric cancer. Scand J Gastroenterol Suppl 1996; 215: 32-7
36. Lee A, Dixon MF, Danon SJ et al. Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995; 7: 461-5
37. Blaser MJ, Chyou PH, Nomura A. Age at establishment of Helicobacter pylori infection and gastric carcinoma, gastric ulcer, and duodenal ulcer risk. Cancer Res 1995; 55: 562-5
38. Dixon MF. Acid, ulcers and H pylori. Lancet 1993; 342: 383-4
39. Covacci A, Censini S, Bugnoli M et al. Molecular characterisation of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993; 90: 5791-5
40. Kuipers EJ, Pérez-Pérez GI, Meuwissen SGM, Blaser MJ. Helicobacter pylori and atrophic gastritis: importance of the Cag A status. J Natl Cancer Inst 1995; 87: 1777-80
41. Blaser MJ, Pérez-Pérez GI, Kleanthous H et al. Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-5
42. Parsonnet J, Friedman GD, Orentreich N, Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997; 40: 297-301
43. Mitchell HM, Hazell SL, Li YY, Hu PJ. Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country. Am J Gastroenterol 1996; 91: 1785-8
44. Crabtree JE, Spencer J. Immunologic aspects of Helicobacter pylori infection and malignant transformation of B cells. Semin Gastroentest Dis 1996; 7: 30-40
45. Craanen ME, Dekker W, Blok P, Ferwerda J, Tytgat GNJ. Intestinal metaplasia and Helicobacter pylori: an endoscopic-bioptic study of the gastric antrum. Gut 1992; 33: 16-20
46. Cayla R, Carles B, de Mascarel A, Zerbib F, Lamoulliatte H. Long term follow up chronic gastritis after persistent Helicobacter pylori eradication in duodenal ulcer patients [Abstract]. Gastroenterology 1995; 108: A68
47. Wyatt JI, Warren CW. Frequency of intestinal metaplasia after H. pylori eradication in duodenal ulcer patients [Abstract]. Gut 1994; 51: A36
48. Van der Hulst RWM, Koycu B, Rauws EAJ, Dekker FW, Tytgat GNJ, Ten Kate FJW. The influence of cure of Helicobacter pylori infection on the long-term sequelae of Helicobacter pylori gastritis [Abstract]. Gastroenterology 1997; 112: A320
49. Haruma K, Mihara M, Kamada T et al. Eradication of Helicobacter pylori reverses intestinal metaplasia in patients with severe atrophic gastritis [Abstract]. Gastroenterology 1997; 112: A142
50. Griffiths AE, Thursz MR, Walker MM. Do intestinal metaplasia and gastric atrophy reverse after H pylori eradication [Abstract] Gut 1997; 43: A48-9
51. Uemura N, Mukai T, Okamoto S et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 639-42
52. Schlemper RJ, Itabashi M, Kato Y et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 1997; 349: 1725-9
53. Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate tor clinical trials. Lancet 1996; 348: 150-4
54. Blaser MJ. Not all Helicobacter pylori strains are created equal: should all be eliminated? Lancet 1997; 349: 1020-2
55. Labenz J, Blum AL, Bayerdörffer E, Meining A, Stolte M, Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux oesophagitis. Gastroenterology 1997; 112: 1442-7
56. Chow WH, Blaser MJ, Blot WJ et al. H pylori and CagA status in relation to risk of adenocarcinomas of oesophagus and stomach by anatomic subsite [Abstract]. Gut 1997; 41: A33-4
57. Danesh J, Forman D, Collins R, Peto R. Helicobacter pylori screening and gastric cancer. Lancet 1996; 348: 758-9